The 2-Minute Rule for ABBV-744 in the treatment of drug-resistant cancers
Additional studies in progress suggest that ARV-825 may also be effective in boosting the response to estrogen deprivation (aromatase inhibition), another ingredient of normal of care in ER+ breast cancer.Over-all, our latest work highlights the potential utilization of ARV-825 in combination with TAM. When ABBV-744 could also suppress proliferativ